![IDSA on Twitter: "A new article in CID describes trends and clinical characteristics among patients with SARS-CoV-2 vaccine-breakthrough infections who were hospitalized at a single center in Florida: https://t.co/45436fRglk #ClinInfectDis ... IDSA on Twitter: "A new article in CID describes trends and clinical characteristics among patients with SARS-CoV-2 vaccine-breakthrough infections who were hospitalized at a single center in Florida: https://t.co/45436fRglk #ClinInfectDis ...](https://pbs.twimg.com/media/FEFvpnRXMAghN-2.jpg)
IDSA on Twitter: "A new article in CID describes trends and clinical characteristics among patients with SARS-CoV-2 vaccine-breakthrough infections who were hospitalized at a single center in Florida: https://t.co/45436fRglk #ClinInfectDis ...
![IDSA on Twitter: "CID: During the 1st COVID-19 wave in South Africa, similar antibody responses were seen in people not infected w/ HIV & people w/ HIV on antiretroviral therapy, suggesting vaccines IDSA on Twitter: "CID: During the 1st COVID-19 wave in South Africa, similar antibody responses were seen in people not infected w/ HIV & people w/ HIV on antiretroviral therapy, suggesting vaccines](https://pbs.twimg.com/media/FAuEd5yX0AUGcQb.jpg)
IDSA on Twitter: "CID: During the 1st COVID-19 wave in South Africa, similar antibody responses were seen in people not infected w/ HIV & people w/ HIV on antiretroviral therapy, suggesting vaccines
![IDSA on Twitter: "A new CID study finds that seroconversion after SARS-CoV-2 infection confers protection against reinfection lasting at least 8 months, which may help global health authorities establish priorities for vaccine IDSA on Twitter: "A new CID study finds that seroconversion after SARS-CoV-2 infection confers protection against reinfection lasting at least 8 months, which may help global health authorities establish priorities for vaccine](https://pbs.twimg.com/media/E5FFrj7WUAEQBRR.png)
IDSA on Twitter: "A new CID study finds that seroconversion after SARS-CoV-2 infection confers protection against reinfection lasting at least 8 months, which may help global health authorities establish priorities for vaccine
Infectious Diseases Society of America - IDSA's Clinical Infectious Diseases journal is keeping you up to date with curated content collections. See our November collections on COVID testing, STIs, hepatitis and TB.
![IDSA on Twitter: "IDSA is pleased to announce that @PaulSaxMD has been named the next editor-in-chief of Clinical Infectious Diseases. 🎉 #IDSAJournals #ClinInfectDis https://t.co/V6kHA6JvDd" / Twitter IDSA on Twitter: "IDSA is pleased to announce that @PaulSaxMD has been named the next editor-in-chief of Clinical Infectious Diseases. 🎉 #IDSAJournals #ClinInfectDis https://t.co/V6kHA6JvDd" / Twitter](https://pbs.twimg.com/media/FLPj2DgVQAgUvm0.jpg)
IDSA on Twitter: "IDSA is pleased to announce that @PaulSaxMD has been named the next editor-in-chief of Clinical Infectious Diseases. 🎉 #IDSAJournals #ClinInfectDis https://t.co/V6kHA6JvDd" / Twitter
Infectious Diseases Society of America - A recent CID supplement features eight articles that have informed the scientific underpinning of interventions that have become key parts of the public health response to
![IDSA on Twitter: "A new multicenter case-control analysis in CID found that during March–May 2021, SARS-CoV-2 mRNA vaccines were highly effective at preventing COVID hospitalizations among U.S. adults. 📄:https://t.co/Hyj3whzd3d #IDSAJournals ... IDSA on Twitter: "A new multicenter case-control analysis in CID found that during March–May 2021, SARS-CoV-2 mRNA vaccines were highly effective at preventing COVID hospitalizations among U.S. adults. 📄:https://t.co/Hyj3whzd3d #IDSAJournals ...](https://pbs.twimg.com/media/E9w8gf5XMAA35zn.png)
IDSA on Twitter: "A new multicenter case-control analysis in CID found that during March–May 2021, SARS-CoV-2 mRNA vaccines were highly effective at preventing COVID hospitalizations among U.S. adults. 📄:https://t.co/Hyj3whzd3d #IDSAJournals ...
![IDSA on Twitter: "A prospective cohort study in CID found that long-term COVID-19 symptoms were common, even in those with mild disease. Female and obese patients recovered more slowly, regardless of age IDSA on Twitter: "A prospective cohort study in CID found that long-term COVID-19 symptoms were common, even in those with mild disease. Female and obese patients recovered more slowly, regardless of age](https://pbs.twimg.com/media/FAtbfs9XEAEvvPF.jpg)
IDSA on Twitter: "A prospective cohort study in CID found that long-term COVID-19 symptoms were common, even in those with mild disease. Female and obese patients recovered more slowly, regardless of age
![PDF) 2017 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea PDF) 2017 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea](https://i1.rgstatic.net/publication/321371076_2017_Infectious_Diseases_Society_of_America_Clinical_Practice_Guidelines_for_the_Diagnosis_and_Management_of_Infectious_Diarrhea/links/5ca16d6292851cf0aea569dd/largepreview.png)
PDF) 2017 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea
![USPHS/IDSA Guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus | Clinical Infectious Diseases | Oxford Academic USPHS/IDSA Guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus | Clinical Infectious Diseases | Oxford Academic](https://oup-silverchair-cdn-com.eres.qnl.qa/oup/backfile/Content_public/Journal/cid/Issue/21/Supplement_1/3/m_cover.jpeg?Expires=1637248455&Signature=Tz6Th5sBvyGM~XVALrcAj6Is7soS2PordiP9yAttQvbL38D0TnZ8EJoOOqtVpDsORB~TaK3xzXPVSLgwgomeodbHmM9sTqpAfEyfft4m7kwHeAel~hC-CoZbJ8gXydF0ESpTPjY6xcxmO-vO43ak~cljyDG7pAU~vGSOyRfITEf1P0emwfkrvj5LPtaS6Hfag~uK3A~DlmBgHTvVxEHJOKyxvXgYpU5PYcKfJPQMvDUjC6E-HdRx54WElGcWRPxYxo8ccU8FRlUDytvnvghKlDkOnWiKzBqk9zJOk2KyWtRVgKXE~XvosDr9BmRuNciTn~WECxaAsoiWaHZVb7J0Ag__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)